SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005983
Filing Date
2016-05-13
Accepted
2016-05-13 16:08:11
Documents
51
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20160331x10q.htm 10-Q 1593016
2 EX-31.1 edit-20160331ex311e2e47f.htm EX-31.1 18489
3 EX-31.2 edit-20160331ex3122b9ae4.htm EX-31.2 18117
4 EX-32.1 edit-20160331ex3216fc604.htm EX-32.1 13339
  Complete submission text file 0001558370-16-005983.txt   5016624

Data Files

Seq Description Document Type Size
5 EX-101.INS edit-20160331.xml EX-101.INS 858101
6 EX-101.SCH edit-20160331.xsd EX-101.SCH 40901
7 EX-101.CAL edit-20160331_cal.xml EX-101.CAL 31742
8 EX-101.DEF edit-20160331_def.xml EX-101.DEF 157141
9 EX-101.LAB edit-20160331_lab.xml EX-101.LAB 387534
10 EX-101.PRE edit-20160331_pre.xml EX-101.PRE 261050
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 161648420
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences